Masahiro Onozawa

29PUBLICATIONS
90CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Learning analyticsFoetal development and medicineSpeciation and extinction
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jul 30, 2026
Regional practice differences significantly impact benefit from post-HCT gilteritinib for FLT3-ITD AML.

|Apr 22, 2026
Philadelphia chromosome-negative but BCR::ABL1-positive acute lymphoblastic leukemia: a real-world multicenter cohort study.

|Mar 20, 2026
Real-world treatment patterns and clinical outcomes in patients with AML from 65 to 74 years unfit for first-line intensive chemotherapy in Japan.

Fumiaki Fujii, Masahiro Onozawa, Shota Yoshida

|Feb 07, 2026
Clustering of students in pre-clinical medical education and identification of academic performance profiles: does online education work for all medical students?

Houman Goudarzi, Masahiro Onozawa, Yoichi M Ito

|Jul 03, 2025
Comparable outcomes with 14-, 21-, or standard 28-day venetoclax in the first cycle of azacitidine-venetoclax in untreated acute myeloid leukemia: real-world experience from the Hokkaido Leukemia Net.

Minoru Kanaya, Masahiro Onozawa, Toshihiro Matsukawa

|Apr 28, 2025
An Autopsy Case of Amyotrophic Lateral Sclerosis With Sudden Death Showed Histological Features of Lewy Body Disease.

Shunsuke Miyachi, Yuki Oshima, Kazuo Yazaki

Pageof 5

Frequent Collaborators

10 joint publications

Takanori Teshima

8 joint publications

Akio Mori

7 joint publications

Takeshi Kondo

5 joint publications

Makoto Saito